nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—CYP1A1—head and neck cancer	0.304	1	CbGaD
Estradiol—NR1I2—Docetaxel—head and neck cancer	0.114	0.234	CbGbCtD
Estradiol—ABCC10—Docetaxel—head and neck cancer	0.0801	0.164	CbGbCtD
Estradiol—SLCO1B3—Docetaxel—head and neck cancer	0.0447	0.0918	CbGbCtD
Estradiol—CYP1B1—Docetaxel—head and neck cancer	0.0435	0.0894	CbGbCtD
Estradiol—SLC22A2—Vinblastine—head and neck cancer	0.034	0.0698	CbGbCtD
Estradiol—ABCG2—Fluorouracil—head and neck cancer	0.0271	0.0556	CbGbCtD
Estradiol—ABCG2—Docetaxel—head and neck cancer	0.0207	0.0425	CbGbCtD
Estradiol—ALB—Fluorouracil—head and neck cancer	0.0187	0.0384	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0153	0.0314	CbGbCtD
Estradiol—CYP3A7—Docetaxel—head and neck cancer	0.0153	0.0314	CbGbCtD
Estradiol—CYP2C8—Fluorouracil—head and neck cancer	0.0144	0.0296	CbGbCtD
Estradiol—CYP3A5—Docetaxel—head and neck cancer	0.0115	0.0235	CbGbCtD
Estradiol—CYP1A2—Fluorouracil—head and neck cancer	0.0112	0.0229	CbGbCtD
Estradiol—CYP2C9—Fluorouracil—head and neck cancer	0.0101	0.0207	CbGbCtD
Estradiol—ABCB1—Vinblastine—head and neck cancer	0.00905	0.0186	CbGbCtD
Estradiol—AR—duct of salivary gland—head and neck cancer	0.00746	0.198	CbGeAlD
Estradiol—ABCB1—Docetaxel—head and neck cancer	0.00746	0.0153	CbGbCtD
Estradiol—CYP3A4—Vinblastine—head and neck cancer	0.00542	0.0111	CbGbCtD
Estradiol—CYP3A4—Docetaxel—head and neck cancer	0.00447	0.00918	CbGbCtD
Estradiol—FABP2—epithelium—head and neck cancer	0.00164	0.0435	CbGeAlD
Estradiol—GPER1—thyroid gland—head and neck cancer	0.00104	0.0276	CbGeAlD
Estradiol—GPER1—head—head and neck cancer	0.00092	0.0245	CbGeAlD
Estradiol—SLC22A3—tongue—head and neck cancer	0.000848	0.0225	CbGeAlD
Estradiol—ESRRA—parotid gland—head and neck cancer	0.000825	0.0219	CbGeAlD
Estradiol—ESRRA—saliva-secreting gland—head and neck cancer	0.00079	0.021	CbGeAlD
Estradiol—NR1I2—head—head and neck cancer	0.000769	0.0204	CbGeAlD
Estradiol—FABP2—lymph node—head and neck cancer	0.000711	0.0189	CbGeAlD
Estradiol—CYP1B1—hair follicle—head and neck cancer	0.000668	0.0177	CbGeAlD
Estradiol—GPER1—lymph node—head and neck cancer	0.000644	0.0171	CbGeAlD
Estradiol—ESRRA—trachea—head and neck cancer	0.00061	0.0162	CbGeAlD
Estradiol—ESR2—neck—head and neck cancer	0.000608	0.0162	CbGeAlD
Estradiol—SHBG—neck—head and neck cancer	0.000591	0.0157	CbGeAlD
Estradiol—SLC22A3—mouth—head and neck cancer	0.00057	0.0152	CbGeAlD
Estradiol—ESRRA—thyroid gland—head and neck cancer	0.000482	0.0128	CbGeAlD
Estradiol—ABCC10—parotid gland—head and neck cancer	0.000464	0.0123	CbGeAlD
Estradiol—ABCC10—saliva-secreting gland—head and neck cancer	0.000444	0.0118	CbGeAlD
Estradiol—Dermatitis contact—Fluorouracil—head and neck cancer	0.000442	0.00477	CcSEcCtD
Estradiol—ESR2—connective tissue—head and neck cancer	0.000436	0.0116	CbGeAlD
Estradiol—Face oedema—Hydroxyurea—head and neck cancer	0.000435	0.0047	CcSEcCtD
Estradiol—Neuritis—Docetaxel—head and neck cancer	0.000432	0.00467	CcSEcCtD
Estradiol—ESRRA—head—head and neck cancer	0.000428	0.0114	CbGeAlD
Estradiol—SHBG—connective tissue—head and neck cancer	0.000424	0.0113	CbGeAlD
Estradiol—Rash erythematous—Docetaxel—head and neck cancer	0.000421	0.00455	CcSEcCtD
Estradiol—ESR1—neck—head and neck cancer	0.000416	0.0111	CbGeAlD
Estradiol—Otitis media—Docetaxel—head and neck cancer	0.000414	0.00447	CcSEcCtD
Estradiol—ESR2—epithelium—head and neck cancer	0.000414	0.011	CbGeAlD
Estradiol—SLCO4A1—trachea—head and neck cancer	0.000413	0.011	CbGeAlD
Estradiol—SLCO1C1—thyroid gland—head and neck cancer	0.000407	0.0108	CbGeAlD
Estradiol—Breast disorder—Hydroxyurea—head and neck cancer	0.000407	0.0044	CcSEcCtD
Estradiol—Myocardial ischaemia—Docetaxel—head and neck cancer	0.000401	0.00433	CcSEcCtD
Estradiol—SLC22A3—parotid gland—head and neck cancer	0.000397	0.0105	CbGeAlD
Estradiol—Rigors—Docetaxel—head and neck cancer	0.000395	0.00427	CcSEcCtD
Estradiol—Pancreatitis—Hydroxyurea—head and neck cancer	0.000382	0.00412	CcSEcCtD
Estradiol—SLC22A3—saliva-secreting gland—head and neck cancer	0.00038	0.0101	CbGeAlD
Estradiol—Depression—Vinblastine—head and neck cancer	0.00038	0.0041	CcSEcCtD
Estradiol—Eye irritation—Docetaxel—head and neck cancer	0.000378	0.00408	CcSEcCtD
Estradiol—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000375	0.00405	CcSEcCtD
Estradiol—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000375	0.00405	CcSEcCtD
Estradiol—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000373	0.00403	CcSEcCtD
Estradiol—Myocardial infarction—Vinblastine—head and neck cancer	0.000373	0.00403	CcSEcCtD
Estradiol—CYP1A1—mouth—head and neck cancer	0.00037	0.00984	CbGeAlD
Estradiol—Swelling—Fluorouracil—head and neck cancer	0.000368	0.00397	CcSEcCtD
Estradiol—Amenorrhoea—Docetaxel—head and neck cancer	0.000367	0.00396	CcSEcCtD
Estradiol—Chest discomfort—Docetaxel—head and neck cancer	0.000364	0.00394	CcSEcCtD
Estradiol—SLCO1C1—head—head and neck cancer	0.000361	0.0096	CbGeAlD
Estradiol—Bone disorder—Docetaxel—head and neck cancer	0.000357	0.00386	CcSEcCtD
Estradiol—Weight increased—Hydroxyurea—head and neck cancer	0.000354	0.00383	CcSEcCtD
Estradiol—AOX1—trachea—head and neck cancer	0.000352	0.00936	CbGeAlD
Estradiol—SLC22A3—connective tissue—head and neck cancer	0.000349	0.00928	CbGeAlD
Estradiol—Drug interaction—Docetaxel—head and neck cancer	0.000348	0.00376	CcSEcCtD
Estradiol—Infestation NOS—Hydroxyurea—head and neck cancer	0.000347	0.00375	CcSEcCtD
Estradiol—Infestation—Hydroxyurea—head and neck cancer	0.000347	0.00375	CcSEcCtD
Estradiol—Amnesia—Fluorouracil—head and neck cancer	0.000345	0.00373	CcSEcCtD
Estradiol—Haemoglobin—Vinblastine—head and neck cancer	0.000344	0.00371	CcSEcCtD
Estradiol—ABCC10—trachea—head and neck cancer	0.000343	0.00911	CbGeAlD
Estradiol—Haemorrhage—Vinblastine—head and neck cancer	0.000342	0.00369	CcSEcCtD
Estradiol—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00034	0.00368	CcSEcCtD
Estradiol—Hypoaesthesia—Vinblastine—head and neck cancer	0.00034	0.00367	CcSEcCtD
Estradiol—Pharyngitis—Vinblastine—head and neck cancer	0.000339	0.00366	CcSEcCtD
Estradiol—Hearing impaired—Docetaxel—head and neck cancer	0.000339	0.00366	CcSEcCtD
Estradiol—Bone pain—Docetaxel—head and neck cancer	0.000337	0.00364	CcSEcCtD
Estradiol—Inflammation—Docetaxel—head and neck cancer	0.000332	0.00359	CcSEcCtD
Estradiol—Lethargy—Fluorouracil—head and neck cancer	0.000331	0.00358	CcSEcCtD
Estradiol—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000328	0.00355	CcSEcCtD
Estradiol—SLCO4A1—thyroid gland—head and neck cancer	0.000326	0.00867	CbGeAlD
Estradiol—Osteoarthritis—Fluorouracil—head and neck cancer	0.000324	0.0035	CcSEcCtD
Estradiol—Pulmonary embolism—Docetaxel—head and neck cancer	0.000323	0.00348	CcSEcCtD
Estradiol—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000323	0.00348	CcSEcCtD
Estradiol—Blood pressure increased—Docetaxel—head and neck cancer	0.000323	0.00348	CcSEcCtD
Estradiol—CYP1B1—connective tissue—head and neck cancer	0.000321	0.00853	CbGeAlD
Estradiol—ESR2—lymphoid tissue—head and neck cancer	0.000319	0.00847	CbGeAlD
Estradiol—Haemoglobin—Hydroxyurea—head and neck cancer	0.000313	0.00338	CcSEcCtD
Estradiol—Influenza like illness—Docetaxel—head and neck cancer	0.000313	0.00338	CcSEcCtD
Estradiol—Haemorrhage—Hydroxyurea—head and neck cancer	0.000312	0.00337	CcSEcCtD
Estradiol—Irritability—Fluorouracil—head and neck cancer	0.00031	0.00334	CcSEcCtD
Estradiol—Candida infection—Docetaxel—head and neck cancer	0.000308	0.00333	CcSEcCtD
Estradiol—Skin exfoliation—Docetaxel—head and neck cancer	0.000308	0.00333	CcSEcCtD
Estradiol—Fluid retention—Docetaxel—head and neck cancer	0.000306	0.00331	CcSEcCtD
Estradiol—AR—connective tissue—head and neck cancer	0.000304	0.00808	CbGeAlD
Estradiol—Alopecia—Vinblastine—head and neck cancer	0.000302	0.00326	CcSEcCtD
Estradiol—ESRRA—lymph node—head and neck cancer	0.0003	0.00796	CbGeAlD
Estradiol—ABCC10—lymphoid tissue—head and neck cancer	0.000299	0.00793	CbGeAlD
Estradiol—ESR1—connective tissue—head and neck cancer	0.000299	0.00793	CbGeAlD
Estradiol—Dry skin—Fluorouracil—head and neck cancer	0.000297	0.00321	CcSEcCtD
Estradiol—Neoplasm—Docetaxel—head and neck cancer	0.000292	0.00315	CcSEcCtD
Estradiol—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00029	0.00313	CcSEcCtD
Estradiol—SLCO4A1—head—head and neck cancer	0.00029	0.0077	CbGeAlD
Estradiol—ESR2—thyroid gland—head and neck cancer	0.000289	0.00769	CbGeAlD
Estradiol—AR—epithelium—head and neck cancer	0.000289	0.00767	CbGeAlD
Estradiol—ESR1—epithelium—head and neck cancer	0.000283	0.00753	CbGeAlD
Estradiol—Angiopathy—Hydroxyurea—head and neck cancer	0.000283	0.00306	CcSEcCtD
Estradiol—SHBG—thyroid gland—head and neck cancer	0.000281	0.00748	CbGeAlD
Estradiol—Dysphagia—Fluorouracil—head and neck cancer	0.00028	0.00303	CcSEcCtD
Estradiol—Chills—Hydroxyurea—head and neck cancer	0.00028	0.00302	CcSEcCtD
Estradiol—AOX1—thyroid gland—head and neck cancer	0.000279	0.0074	CbGeAlD
Estradiol—Ill-defined disorder—Vinblastine—head and neck cancer	0.000276	0.00298	CcSEcCtD
Estradiol—Alopecia—Hydroxyurea—head and neck cancer	0.000275	0.00298	CcSEcCtD
Estradiol—Phlebitis—Docetaxel—head and neck cancer	0.000272	0.00294	CcSEcCtD
Estradiol—ABCG2—parotid gland—head and neck cancer	0.000272	0.00722	CbGeAlD
Estradiol—Erythema—Hydroxyurea—head and neck cancer	0.000271	0.00293	CcSEcCtD
Estradiol—ABCC10—thyroid gland—head and neck cancer	0.000271	0.00721	CbGeAlD
Estradiol—Thrombophlebitis—Docetaxel—head and neck cancer	0.00027	0.00292	CcSEcCtD
Estradiol—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000269	0.00291	CcSEcCtD
Estradiol—Malaise—Vinblastine—head and neck cancer	0.000268	0.0029	CcSEcCtD
Estradiol—Vertigo—Vinblastine—head and neck cancer	0.000267	0.00289	CcSEcCtD
Estradiol—Swelling—Docetaxel—head and neck cancer	0.000265	0.00287	CcSEcCtD
Estradiol—Deafness—Docetaxel—head and neck cancer	0.000262	0.00283	CcSEcCtD
Estradiol—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000261	0.00281	CcSEcCtD
Estradiol—ABCG2—saliva-secreting gland—head and neck cancer	0.00026	0.00692	CbGeAlD
Estradiol—CYP1A1—parotid gland—head and neck cancer	0.000258	0.00685	CbGeAlD
Estradiol—Hypertension—Vinblastine—head and neck cancer	0.000257	0.00278	CcSEcCtD
Estradiol—ESR2—head—head and neck cancer	0.000257	0.00682	CbGeAlD
Estradiol—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000256	0.00276	CcSEcCtD
Estradiol—SLCO2B1—thyroid gland—head and neck cancer	0.000254	0.00675	CbGeAlD
Estradiol—SLCO1C1—lymph node—head and neck cancer	0.000253	0.00672	CbGeAlD
Estradiol—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000252	0.00272	CcSEcCtD
Estradiol—Pneumonia—Fluorouracil—head and neck cancer	0.000251	0.00272	CcSEcCtD
Estradiol—Discomfort—Vinblastine—head and neck cancer	0.00025	0.0027	CcSEcCtD
Estradiol—Hot flush—Docetaxel—head and neck cancer	0.00025	0.0027	CcSEcCtD
Estradiol—Infestation NOS—Fluorouracil—head and neck cancer	0.00025	0.0027	CcSEcCtD
Estradiol—Infestation—Fluorouracil—head and neck cancer	0.00025	0.0027	CcSEcCtD
Estradiol—Menopausal symptoms—Docetaxel—head and neck cancer	0.000248	0.00268	CcSEcCtD
Estradiol—Visual disturbance—Docetaxel—head and neck cancer	0.000247	0.00267	CcSEcCtD
Estradiol—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000246	0.00266	CcSEcCtD
Estradiol—Myocardial infarction—Fluorouracil—head and neck cancer	0.000245	0.00265	CcSEcCtD
Estradiol—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000245	0.00265	CcSEcCtD
Estradiol—Malaise—Hydroxyurea—head and neck cancer	0.000245	0.00264	CcSEcCtD
Estradiol—Urinary tract infection—Fluorouracil—head and neck cancer	0.000243	0.00262	CcSEcCtD
Estradiol—Conjunctivitis—Fluorouracil—head and neck cancer	0.000243	0.00262	CcSEcCtD
Estradiol—Lethargy—Docetaxel—head and neck cancer	0.000239	0.00258	CcSEcCtD
Estradiol—Epistaxis—Fluorouracil—head and neck cancer	0.000236	0.00255	CcSEcCtD
Estradiol—CYP1B1—lymphoid tissue—head and neck cancer	0.000235	0.00624	CbGeAlD
Estradiol—Sinusitis—Fluorouracil—head and neck cancer	0.000234	0.00253	CcSEcCtD
Estradiol—Pain in extremity—Docetaxel—head and neck cancer	0.000234	0.00253	CcSEcCtD
Estradiol—SLC22A3—thyroid gland—head and neck cancer	0.000232	0.00617	CbGeAlD
Estradiol—Migraine—Docetaxel—head and neck cancer	0.00023	0.00249	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000229	0.00248	CcSEcCtD
Estradiol—Discomfort—Hydroxyurea—head and neck cancer	0.000228	0.00247	CcSEcCtD
Estradiol—Haemoglobin—Fluorouracil—head and neck cancer	0.000226	0.00244	CcSEcCtD
Estradiol—SLCO2B1—head—head and neck cancer	0.000225	0.00599	CbGeAlD
Estradiol—Rhinitis—Fluorouracil—head and neck cancer	0.000225	0.00243	CcSEcCtD
Estradiol—Haemorrhage—Fluorouracil—head and neck cancer	0.000224	0.00242	CcSEcCtD
Estradiol—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000223	0.00241	CcSEcCtD
Estradiol—Pharyngitis—Fluorouracil—head and neck cancer	0.000223	0.00241	CcSEcCtD
Estradiol—AR—lymphoid tissue—head and neck cancer	0.000222	0.00591	CbGeAlD
Estradiol—Oedema—Hydroxyurea—head and neck cancer	0.000221	0.00239	CcSEcCtD
Estradiol—Infection—Hydroxyurea—head and neck cancer	0.00022	0.00238	CcSEcCtD
Estradiol—ESR1—lymphoid tissue—head and neck cancer	0.000218	0.0058	CbGeAlD
Estradiol—Paraesthesia—Vinblastine—head and neck cancer	0.000218	0.00236	CcSEcCtD
Estradiol—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000217	0.00235	CcSEcCtD
Estradiol—Liver function test abnormal—Docetaxel—head and neck cancer	0.000216	0.00233	CcSEcCtD
Estradiol—CYP1A1—epithelium—head and neck cancer	0.000215	0.00573	CbGeAlD
Estradiol—SLC22A1—head—head and neck cancer	0.000215	0.00572	CbGeAlD
Estradiol—Skin disorder—Hydroxyurea—head and neck cancer	0.000215	0.00232	CcSEcCtD
Estradiol—Dry skin—Docetaxel—head and neck cancer	0.000215	0.00232	CcSEcCtD
Estradiol—Abdominal pain upper—Docetaxel—head and neck cancer	0.000214	0.00231	CcSEcCtD
Estradiol—CYP1B1—thyroid gland—head and neck cancer	0.000213	0.00567	CbGeAlD
Estradiol—Breast disorder—Docetaxel—head and neck cancer	0.000212	0.00229	CcSEcCtD
Estradiol—Decreased appetite—Vinblastine—head and neck cancer	0.000211	0.00228	CcSEcCtD
Estradiol—Cramp muscle—Docetaxel—head and neck cancer	0.000211	0.00228	CcSEcCtD
Estradiol—Nasopharyngitis—Docetaxel—head and neck cancer	0.000209	0.00226	CcSEcCtD
Estradiol—Constipation—Vinblastine—head and neck cancer	0.000208	0.00224	CcSEcCtD
Estradiol—Pain—Vinblastine—head and neck cancer	0.000208	0.00224	CcSEcCtD
Estradiol—SLCO1A2—head—head and neck cancer	0.000207	0.00551	CbGeAlD
Estradiol—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000206	0.00223	CcSEcCtD
Estradiol—SLC22A3—head—head and neck cancer	0.000206	0.00547	CbGeAlD
Estradiol—SLCO4A1—lymph node—head and neck cancer	0.000203	0.00539	CbGeAlD
Estradiol—Dysphagia—Docetaxel—head and neck cancer	0.000202	0.00219	CcSEcCtD
Estradiol—AR—thyroid gland—head and neck cancer	0.000202	0.00537	CbGeAlD
Estradiol—Feeling abnormal—Vinblastine—head and neck cancer	0.0002	0.00216	CcSEcCtD
Estradiol—Bronchospasm—Docetaxel—head and neck cancer	0.000199	0.00215	CcSEcCtD
Estradiol—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000199	0.00215	CcSEcCtD
Estradiol—Alopecia—Fluorouracil—head and neck cancer	0.000198	0.00214	CcSEcCtD
Estradiol—ESR1—thyroid gland—head and neck cancer	0.000198	0.00527	CbGeAlD
Estradiol—SLC22A8—head—head and neck cancer	0.000198	0.00526	CbGeAlD
Estradiol—Dyspnoea—Hydroxyurea—head and neck cancer	0.000197	0.00213	CcSEcCtD
Estradiol—Somnolence—Hydroxyurea—head and neck cancer	0.000197	0.00213	CcSEcCtD
Estradiol—Erythema—Fluorouracil—head and neck cancer	0.000195	0.00211	CcSEcCtD
Estradiol—Dyspepsia—Hydroxyurea—head and neck cancer	0.000195	0.00211	CcSEcCtD
Estradiol—Decreased appetite—Hydroxyurea—head and neck cancer	0.000193	0.00208	CcSEcCtD
Estradiol—Abdominal pain—Vinblastine—head and neck cancer	0.000192	0.00207	CcSEcCtD
Estradiol—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000191	0.00207	CcSEcCtD
Estradiol—Fatigue—Hydroxyurea—head and neck cancer	0.000191	0.00206	CcSEcCtD
Estradiol—CYP1A1—trachea—head and neck cancer	0.000191	0.00506	CbGeAlD
Estradiol—Constipation—Hydroxyurea—head and neck cancer	0.000189	0.00205	CcSEcCtD
Estradiol—Pain—Hydroxyurea—head and neck cancer	0.000189	0.00205	CcSEcCtD
Estradiol—CYP1B1—head—head and neck cancer	0.000189	0.00503	CbGeAlD
Estradiol—Weight increased—Docetaxel—head and neck cancer	0.000184	0.00199	CcSEcCtD
Estradiol—Weight decreased—Docetaxel—head and neck cancer	0.000183	0.00198	CcSEcCtD
Estradiol—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000183	0.00197	CcSEcCtD
Estradiol—Pneumonia—Docetaxel—head and neck cancer	0.000181	0.00196	CcSEcCtD
Estradiol—Infestation—Docetaxel—head and neck cancer	0.00018	0.00195	CcSEcCtD
Estradiol—Infestation NOS—Docetaxel—head and neck cancer	0.00018	0.00195	CcSEcCtD
Estradiol—ESR2—lymph node—head and neck cancer	0.00018	0.00478	CbGeAlD
Estradiol—AR—head—head and neck cancer	0.000179	0.00476	CbGeAlD
Estradiol—Hypersensitivity—Vinblastine—head and neck cancer	0.000179	0.00193	CcSEcCtD
Estradiol—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000178	0.00192	CcSEcCtD
Estradiol—Myocardial infarction—Docetaxel—head and neck cancer	0.000177	0.00191	CcSEcCtD
Estradiol—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000177	0.00191	CcSEcCtD
Estradiol—ESR1—head—head and neck cancer	0.000176	0.00467	CbGeAlD
Estradiol—Jaundice—Docetaxel—head and neck cancer	0.000176	0.0019	CcSEcCtD
Estradiol—Conjunctivitis—Docetaxel—head and neck cancer	0.000175	0.00189	CcSEcCtD
Estradiol—Body temperature increased—Hydroxyurea—head and neck cancer	0.000175	0.00189	CcSEcCtD
Estradiol—Asthenia—Vinblastine—head and neck cancer	0.000174	0.00188	CcSEcCtD
Estradiol—AOX1—lymph node—head and neck cancer	0.000173	0.0046	CbGeAlD
Estradiol—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000171	0.00184	CcSEcCtD
Estradiol—Epistaxis—Docetaxel—head and neck cancer	0.00017	0.00184	CcSEcCtD
Estradiol—ABCC10—lymph node—head and neck cancer	0.000168	0.00448	CbGeAlD
Estradiol—Myalgia—Fluorouracil—head and neck cancer	0.000166	0.0018	CcSEcCtD
Estradiol—Chest pain—Fluorouracil—head and neck cancer	0.000166	0.0018	CcSEcCtD
Estradiol—Diarrhoea—Vinblastine—head and neck cancer	0.000166	0.00179	CcSEcCtD
Estradiol—Discomfort—Fluorouracil—head and neck cancer	0.000164	0.00177	CcSEcCtD
Estradiol—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000163	0.00176	CcSEcCtD
Estradiol—Haemoglobin—Docetaxel—head and neck cancer	0.000163	0.00176	CcSEcCtD
Estradiol—Rhinitis—Docetaxel—head and neck cancer	0.000162	0.00175	CcSEcCtD
Estradiol—Haemorrhage—Docetaxel—head and neck cancer	0.000162	0.00175	CcSEcCtD
Estradiol—Hepatitis—Docetaxel—head and neck cancer	0.000162	0.00175	CcSEcCtD
Estradiol—Hypoaesthesia—Docetaxel—head and neck cancer	0.000161	0.00174	CcSEcCtD
Estradiol—Confusional state—Fluorouracil—head and neck cancer	0.000161	0.00174	CcSEcCtD
Estradiol—Pharyngitis—Docetaxel—head and neck cancer	0.000161	0.00174	CcSEcCtD
Estradiol—Dizziness—Vinblastine—head and neck cancer	0.000161	0.00173	CcSEcCtD
Estradiol—Urinary tract disorder—Docetaxel—head and neck cancer	0.00016	0.00173	CcSEcCtD
Estradiol—Oedema peripheral—Docetaxel—head and neck cancer	0.00016	0.00172	CcSEcCtD
Estradiol—Oedema—Fluorouracil—head and neck cancer	0.000159	0.00172	CcSEcCtD
Estradiol—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000159	0.00172	CcSEcCtD
Estradiol—Connective tissue disorder—Docetaxel—head and neck cancer	0.000159	0.00172	CcSEcCtD
Estradiol—Asthenia—Hydroxyurea—head and neck cancer	0.000159	0.00172	CcSEcCtD
Estradiol—ABCG2—thyroid gland—head and neck cancer	0.000159	0.00422	CbGeAlD
Estradiol—Urethral disorder—Docetaxel—head and neck cancer	0.000159	0.00171	CcSEcCtD
Estradiol—Infection—Fluorouracil—head and neck cancer	0.000158	0.00171	CcSEcCtD
Estradiol—SLCO2B1—lymph node—head and neck cancer	0.000158	0.00419	CbGeAlD
Estradiol—Nervous system disorder—Fluorouracil—head and neck cancer	0.000156	0.00169	CcSEcCtD
Estradiol—Visual impairment—Docetaxel—head and neck cancer	0.000156	0.00169	CcSEcCtD
Estradiol—Tachycardia—Fluorouracil—head and neck cancer	0.000156	0.00168	CcSEcCtD
Estradiol—Vomiting—Vinblastine—head and neck cancer	0.000154	0.00167	CcSEcCtD
Estradiol—Erythema multiforme—Docetaxel—head and neck cancer	0.000153	0.00165	CcSEcCtD
Estradiol—CYP1A2—thyroid gland—head and neck cancer	0.000153	0.00406	CbGeAlD
Estradiol—Headache—Vinblastine—head and neck cancer	0.000152	0.00164	CcSEcCtD
Estradiol—Diarrhoea—Hydroxyurea—head and neck cancer	0.000152	0.00164	CcSEcCtD
Estradiol—Eye disorder—Docetaxel—head and neck cancer	0.000151	0.00163	CcSEcCtD
Estradiol—CYP1A1—thyroid gland—head and neck cancer	0.000151	0.00401	CbGeAlD
Estradiol—Cardiac disorder—Docetaxel—head and neck cancer	0.00015	0.00162	CcSEcCtD
Estradiol—Flushing—Docetaxel—head and neck cancer	0.00015	0.00162	CcSEcCtD
Estradiol—Angiopathy—Docetaxel—head and neck cancer	0.000147	0.00159	CcSEcCtD
Estradiol—Dizziness—Hydroxyurea—head and neck cancer	0.000146	0.00158	CcSEcCtD
Estradiol—Immune system disorder—Docetaxel—head and neck cancer	0.000146	0.00158	CcSEcCtD
Estradiol—Mediastinal disorder—Docetaxel—head and neck cancer	0.000146	0.00158	CcSEcCtD
Estradiol—Chills—Docetaxel—head and neck cancer	0.000145	0.00157	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000145	0.00157	CcSEcCtD
Estradiol—ALB—lymph node—head and neck cancer	0.000144	0.00384	CbGeAlD
Estradiol—Nausea—Vinblastine—head and neck cancer	0.000144	0.00156	CcSEcCtD
Estradiol—Insomnia—Fluorouracil—head and neck cancer	0.000144	0.00156	CcSEcCtD
Estradiol—SLC22A3—lymph node—head and neck cancer	0.000144	0.00383	CbGeAlD
Estradiol—Paraesthesia—Fluorouracil—head and neck cancer	0.000143	0.00155	CcSEcCtD
Estradiol—Alopecia—Docetaxel—head and neck cancer	0.000143	0.00155	CcSEcCtD
Estradiol—Dyspnoea—Fluorouracil—head and neck cancer	0.000142	0.00154	CcSEcCtD
Estradiol—Mental disorder—Docetaxel—head and neck cancer	0.000142	0.00153	CcSEcCtD
Estradiol—Somnolence—Fluorouracil—head and neck cancer	0.000142	0.00153	CcSEcCtD
Estradiol—Erythema—Docetaxel—head and neck cancer	0.000141	0.00152	CcSEcCtD
Estradiol—Malnutrition—Docetaxel—head and neck cancer	0.000141	0.00152	CcSEcCtD
Estradiol—Vomiting—Hydroxyurea—head and neck cancer	0.000141	0.00152	CcSEcCtD
Estradiol—Dyspepsia—Fluorouracil—head and neck cancer	0.00014	0.00152	CcSEcCtD
Estradiol—Rash—Hydroxyurea—head and neck cancer	0.00014	0.00151	CcSEcCtD
Estradiol—Dermatitis—Hydroxyurea—head and neck cancer	0.00014	0.00151	CcSEcCtD
Estradiol—Headache—Hydroxyurea—head and neck cancer	0.000139	0.0015	CcSEcCtD
Estradiol—Decreased appetite—Fluorouracil—head and neck cancer	0.000139	0.0015	CcSEcCtD
Estradiol—Dysgeusia—Docetaxel—head and neck cancer	0.000138	0.00149	CcSEcCtD
Estradiol—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000138	0.00149	CcSEcCtD
Estradiol—Back pain—Docetaxel—head and neck cancer	0.000136	0.00147	CcSEcCtD
Estradiol—Pain—Fluorouracil—head and neck cancer	0.000136	0.00147	CcSEcCtD
Estradiol—Muscle spasms—Docetaxel—head and neck cancer	0.000136	0.00146	CcSEcCtD
Estradiol—CYP1A1—head—head and neck cancer	0.000134	0.00355	CbGeAlD
Estradiol—CYP1B1—lymph node—head and neck cancer	0.000132	0.00352	CbGeAlD
Estradiol—Nausea—Hydroxyurea—head and neck cancer	0.000132	0.00142	CcSEcCtD
Estradiol—Feeling abnormal—Fluorouracil—head and neck cancer	0.000131	0.00142	CcSEcCtD
Estradiol—Urticaria—Fluorouracil—head and neck cancer	0.000127	0.00137	CcSEcCtD
Estradiol—Syncope—Docetaxel—head and neck cancer	0.000126	0.00137	CcSEcCtD
Estradiol—Body temperature increased—Fluorouracil—head and neck cancer	0.000126	0.00136	CcSEcCtD
Estradiol—AR—lymph node—head and neck cancer	0.000125	0.00333	CbGeAlD
Estradiol—Palpitations—Docetaxel—head and neck cancer	0.000125	0.00135	CcSEcCtD
Estradiol—Loss of consciousness—Docetaxel—head and neck cancer	0.000124	0.00134	CcSEcCtD
Estradiol—ESR1—lymph node—head and neck cancer	0.000123	0.00327	CbGeAlD
Estradiol—Cough—Docetaxel—head and neck cancer	0.000123	0.00133	CcSEcCtD
Estradiol—Hypertension—Docetaxel—head and neck cancer	0.000122	0.00131	CcSEcCtD
Estradiol—Chest pain—Docetaxel—head and neck cancer	0.00012	0.0013	CcSEcCtD
Estradiol—Arthralgia—Docetaxel—head and neck cancer	0.00012	0.0013	CcSEcCtD
Estradiol—Myalgia—Docetaxel—head and neck cancer	0.00012	0.0013	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000119	0.00129	CcSEcCtD
Estradiol—Hypersensitivity—Fluorouracil—head and neck cancer	0.000117	0.00127	CcSEcCtD
Estradiol—Dry mouth—Docetaxel—head and neck cancer	0.000117	0.00127	CcSEcCtD
Estradiol—Confusional state—Docetaxel—head and neck cancer	0.000116	0.00125	CcSEcCtD
Estradiol—Anaphylactic shock—Docetaxel—head and neck cancer	0.000115	0.00124	CcSEcCtD
Estradiol—Oedema—Docetaxel—head and neck cancer	0.000115	0.00124	CcSEcCtD
Estradiol—Infection—Docetaxel—head and neck cancer	0.000114	0.00123	CcSEcCtD
Estradiol—Shock—Docetaxel—head and neck cancer	0.000113	0.00122	CcSEcCtD
Estradiol—Nervous system disorder—Docetaxel—head and neck cancer	0.000113	0.00122	CcSEcCtD
Estradiol—Pruritus—Fluorouracil—head and neck cancer	0.000113	0.00122	CcSEcCtD
Estradiol—Tachycardia—Docetaxel—head and neck cancer	0.000112	0.00121	CcSEcCtD
Estradiol—ABCB1—epithelium—head and neck cancer	0.000112	0.00297	CbGeAlD
Estradiol—Skin disorder—Docetaxel—head and neck cancer	0.000112	0.00121	CcSEcCtD
Estradiol—Diarrhoea—Fluorouracil—head and neck cancer	0.000109	0.00118	CcSEcCtD
Estradiol—Dizziness—Fluorouracil—head and neck cancer	0.000105	0.00114	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000105	0.00113	CcSEcCtD
Estradiol—Insomnia—Docetaxel—head and neck cancer	0.000104	0.00112	CcSEcCtD
Estradiol—Paraesthesia—Docetaxel—head and neck cancer	0.000103	0.00112	CcSEcCtD
Estradiol—Dyspnoea—Docetaxel—head and neck cancer	0.000103	0.00111	CcSEcCtD
Estradiol—Somnolence—Docetaxel—head and neck cancer	0.000102	0.0011	CcSEcCtD
Estradiol—Vomiting—Fluorouracil—head and neck cancer	0.000101	0.00109	CcSEcCtD
Estradiol—Dyspepsia—Docetaxel—head and neck cancer	0.000101	0.00109	CcSEcCtD
Estradiol—Rash—Fluorouracil—head and neck cancer	0.000101	0.00109	CcSEcCtD
Estradiol—Dermatitis—Fluorouracil—head and neck cancer	0.0001	0.00108	CcSEcCtD
Estradiol—Decreased appetite—Docetaxel—head and neck cancer	0.0001	0.00108	CcSEcCtD
Estradiol—Headache—Fluorouracil—head and neck cancer	9.99e-05	0.00108	CcSEcCtD
Estradiol—Gastrointestinal disorder—Docetaxel—head and neck cancer	9.93e-05	0.00107	CcSEcCtD
Estradiol—Fatigue—Docetaxel—head and neck cancer	9.92e-05	0.00107	CcSEcCtD
Estradiol—ABCB1—trachea—head and neck cancer	9.9e-05	0.00263	CbGeAlD
Estradiol—ABCG2—lymph node—head and neck cancer	9.86e-05	0.00262	CbGeAlD
Estradiol—Constipation—Docetaxel—head and neck cancer	9.84e-05	0.00106	CcSEcCtD
Estradiol—Pain—Docetaxel—head and neck cancer	9.84e-05	0.00106	CcSEcCtD
Estradiol—Feeling abnormal—Docetaxel—head and neck cancer	9.48e-05	0.00102	CcSEcCtD
Estradiol—Nausea—Fluorouracil—head and neck cancer	9.47e-05	0.00102	CcSEcCtD
Estradiol—Gastrointestinal pain—Docetaxel—head and neck cancer	9.41e-05	0.00102	CcSEcCtD
Estradiol—CYP1A1—lymph node—head and neck cancer	9.36e-05	0.00249	CbGeAlD
Estradiol—Abdominal pain—Docetaxel—head and neck cancer	9.1e-05	0.000983	CcSEcCtD
Estradiol—Body temperature increased—Docetaxel—head and neck cancer	9.1e-05	0.000983	CcSEcCtD
Estradiol—ABCB1—lymphoid tissue—head and neck cancer	8.62e-05	0.00229	CbGeAlD
Estradiol—Hypersensitivity—Docetaxel—head and neck cancer	8.48e-05	0.000916	CcSEcCtD
Estradiol—Asthenia—Docetaxel—head and neck cancer	8.26e-05	0.000892	CcSEcCtD
Estradiol—Pruritus—Docetaxel—head and neck cancer	8.14e-05	0.000879	CcSEcCtD
Estradiol—Diarrhoea—Docetaxel—head and neck cancer	7.87e-05	0.00085	CcSEcCtD
Estradiol—ABCB1—thyroid gland—head and neck cancer	7.83e-05	0.00208	CbGeAlD
Estradiol—Dizziness—Docetaxel—head and neck cancer	7.61e-05	0.000822	CcSEcCtD
Estradiol—Vomiting—Docetaxel—head and neck cancer	7.32e-05	0.00079	CcSEcCtD
Estradiol—Rash—Docetaxel—head and neck cancer	7.25e-05	0.000784	CcSEcCtD
Estradiol—Dermatitis—Docetaxel—head and neck cancer	7.25e-05	0.000783	CcSEcCtD
Estradiol—Headache—Docetaxel—head and neck cancer	7.21e-05	0.000779	CcSEcCtD
Estradiol—ABCB1—head—head and neck cancer	6.95e-05	0.00185	CbGeAlD
Estradiol—Nausea—Docetaxel—head and neck cancer	6.83e-05	0.000738	CcSEcCtD
Estradiol—ABCB1—lymph node—head and neck cancer	4.86e-05	0.00129	CbGeAlD
Estradiol—SLC22A2—Neuronal System—HRAS—head and neck cancer	1.33e-05	0.000168	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NAT2—head and neck cancer	1.32e-05	0.000167	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.32e-05	0.000166	CbGpPWpGaD
Estradiol—ALB—Metabolism—NAT2—head and neck cancer	1.32e-05	0.000166	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PTGS2—head and neck cancer	1.31e-05	0.000165	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	1.31e-05	0.000165	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.29e-05	0.000162	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.28e-05	0.000161	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—GPX1—head and neck cancer	1.27e-05	0.000161	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—YAP1—head and neck cancer	1.27e-05	0.00016	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—DPYD—head and neck cancer	1.26e-05	0.00016	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	1.26e-05	0.000159	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—TYMS—head and neck cancer	1.25e-05	0.000159	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.25e-05	0.000159	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.25e-05	0.000158	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	1.24e-05	0.000157	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.24e-05	0.000157	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—GSTM1—head and neck cancer	1.24e-05	0.000157	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—HRAS—head and neck cancer	1.24e-05	0.000156	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.22e-05	0.000155	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.22e-05	0.000154	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—AKT1—head and neck cancer	1.22e-05	0.000154	CbGpPWpGaD
Estradiol—AOX1—Disease—STAT3—head and neck cancer	1.22e-05	0.000154	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—YAP1—head and neck cancer	1.2e-05	0.000152	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—GPX1—head and neck cancer	1.19e-05	0.00015	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NAT2—head and neck cancer	1.18e-05	0.000149	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CYP1A1—head and neck cancer	1.18e-05	0.000149	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—TYMS—head and neck cancer	1.17e-05	0.000148	CbGpPWpGaD
Estradiol—AOX1—Disease—MAPK3—head and neck cancer	1.17e-05	0.000147	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—PIK3CA—head and neck cancer	1.16e-05	0.000147	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—DPYD—head and neck cancer	1.16e-05	0.000146	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—GSTM1—head and neck cancer	1.16e-05	0.000146	CbGpPWpGaD
Estradiol—ALB—Metabolism—DPYD—head and neck cancer	1.15e-05	0.000146	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—MAPK3—head and neck cancer	1.15e-05	0.000146	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NAT2—head and neck cancer	1.15e-05	0.000146	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—TYMS—head and neck cancer	1.15e-05	0.000145	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.14e-05	0.000144	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PTEN—head and neck cancer	1.14e-05	0.000144	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—GSTM1—head and neck cancer	1.14e-05	0.000144	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.13e-05	0.000143	CbGpPWpGaD
Estradiol—AOX1—Disease—MAPK1—head and neck cancer	1.11e-05	0.00014	CbGpPWpGaD
Estradiol—AOX1—Disease—EGFR—head and neck cancer	1.11e-05	0.00014	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—GPX1—head and neck cancer	1.11e-05	0.00014	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—AKT1—head and neck cancer	1.1e-05	0.00014	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—YAP1—head and neck cancer	1.1e-05	0.000139	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CYP1A1—head and neck cancer	1.1e-05	0.000139	CbGpPWpGaD
Estradiol—ALB—Metabolism—YAP1—head and neck cancer	1.09e-05	0.000138	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—GPX1—head and neck cancer	1.09e-05	0.000138	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.08e-05	0.000136	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	1.08e-05	0.000136	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NAT2—head and neck cancer	1.08e-05	0.000136	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—TYMS—head and neck cancer	1.06e-05	0.000135	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.06e-05	0.000134	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—TYMS—head and neck cancer	1.06e-05	0.000133	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—TYMS—head and neck cancer	1.05e-05	0.000133	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—GSTM1—head and neck cancer	1.05e-05	0.000133	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—NOTCH1—head and neck cancer	1.05e-05	0.000133	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.04e-05	0.000132	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—GSTM1—head and neck cancer	1.04e-05	0.000132	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.04e-05	0.000131	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—DPYD—head and neck cancer	1.04e-05	0.000131	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.03e-05	0.00013	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—DPYD—head and neck cancer	1.01e-05	0.000128	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—GPX1—head and neck cancer	1.01e-05	0.000127	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—GPX1—head and neck cancer	9.99e-06	0.000126	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CYP1A1—head and neck cancer	9.98e-06	0.000126	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—GPX1—head and neck cancer	9.98e-06	0.000126	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CYP1A1—head and neck cancer	9.89e-06	0.000125	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CYP1A1—head and neck cancer	9.88e-06	0.000125	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—YAP1—head and neck cancer	9.82e-06	0.000124	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—TYMS—head and neck cancer	9.82e-06	0.000124	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.77e-06	0.000123	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GSTM1—head and neck cancer	9.71e-06	0.000123	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.67e-06	0.000122	CbGpPWpGaD
Estradiol—AOX1—Disease—PIK3CA—head and neck cancer	9.62e-06	0.000122	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—YAP1—head and neck cancer	9.59e-06	0.000121	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—head and neck cancer	9.54e-06	0.00012	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—AKT1—head and neck cancer	9.5e-06	0.00012	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—DPYD—head and neck cancer	9.44e-06	0.000119	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—head and neck cancer	9.36e-06	0.000118	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—GPX1—head and neck cancer	9.3e-06	0.000117	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CYP1A1—head and neck cancer	9.2e-06	0.000116	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NAT2—head and neck cancer	9.2e-06	0.000116	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.02e-06	0.000114	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.01e-06	0.000114	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—YAP1—head and neck cancer	8.96e-06	0.000113	CbGpPWpGaD
Estradiol—AOX1—Disease—HRAS—head and neck cancer	8.9e-06	0.000112	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.85e-06	0.000112	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	8.81e-06	0.000111	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.67e-06	0.00011	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2—head and neck cancer	8.37e-06	0.000106	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTEN—head and neck cancer	8.32e-06	0.000105	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.27e-06	0.000104	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.22e-06	0.000104	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTEN—head and neck cancer	8.17e-06	0.000103	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—DPYD—head and neck cancer	8.07e-06	0.000102	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PIK3CA—head and neck cancer	8.06e-06	0.000102	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.87e-06	9.94e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—AKT1—head and neck cancer	7.86e-06	9.93e-05	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—AKT1—head and neck cancer	7.77e-06	9.82e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—YAP1—head and neck cancer	7.65e-06	9.67e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—TYMS—head and neck cancer	7.63e-06	9.64e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MAPK3—head and neck cancer	7.54e-06	9.53e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GSTM1—head and neck cancer	7.54e-06	9.53e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—head and neck cancer	7.49e-06	9.47e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.38e-06	9.32e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GPX1—head and neck cancer	7.22e-06	9.12e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.21e-06	9.11e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—TYMS—head and neck cancer	7.21e-06	9.11e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.17e-06	9.06e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP1A1—head and neck cancer	7.15e-06	9.03e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTM1—head and neck cancer	7.12e-06	9e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—head and neck cancer	7.11e-06	8.99e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NAT2—head and neck cancer	7.1e-06	8.97e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—head and neck cancer	6.99e-06	8.83e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	6.83e-06	8.63e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GPX1—head and neck cancer	6.82e-06	8.62e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.73e-06	8.5e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK3—head and neck cancer	6.73e-06	8.5e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—TYMS—head and neck cancer	6.61e-06	8.35e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—AKT1—head and neck cancer	6.58e-06	8.32e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—TYMS—head and neck cancer	6.57e-06	8.3e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—head and neck cancer	6.54e-06	8.26e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTM1—head and neck cancer	6.53e-06	8.25e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—head and neck cancer	6.52e-06	8.24e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTM1—head and neck cancer	6.49e-06	8.2e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.44e-06	8.13e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—head and neck cancer	6.41e-06	8.1e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK1—head and neck cancer	6.4e-06	8.09e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GPX1—head and neck cancer	6.26e-06	7.9e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—DPYD—head and neck cancer	6.22e-06	7.86e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GPX1—head and neck cancer	6.22e-06	7.86e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP1A1—head and neck cancer	6.19e-06	7.82e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP1A1—head and neck cancer	6.16e-06	7.78e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—head and neck cancer	6.1e-06	7.7e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—head and neck cancer	5.93e-06	7.5e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—YAP1—head and neck cancer	5.91e-06	7.46e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—TYMS—head and neck cancer	5.9e-06	7.45e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—head and neck cancer	5.88e-06	7.43e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—head and neck cancer	5.87e-06	7.42e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.87e-06	7.41e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—head and neck cancer	5.87e-06	7.41e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTM1—head and neck cancer	5.83e-06	7.37e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MAPK3—head and neck cancer	5.81e-06	7.34e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—head and neck cancer	5.76e-06	7.28e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—TYMS—head and neck cancer	5.76e-06	7.27e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.75e-06	7.26e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTM1—head and neck cancer	5.69e-06	7.19e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—head and neck cancer	5.69e-06	7.19e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—head and neck cancer	5.59e-06	7.06e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GPX1—head and neck cancer	5.58e-06	7.05e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—head and neck cancer	5.56e-06	7.02e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.55e-06	7.01e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.53e-06	6.98e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—head and neck cancer	5.47e-06	6.91e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GPX1—head and neck cancer	5.45e-06	6.88e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.39e-06	6.81e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—TYMS—head and neck cancer	5.38e-06	6.79e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—head and neck cancer	5.38e-06	6.79e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTM1—head and neck cancer	5.32e-06	6.72e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—head and neck cancer	5.18e-06	6.54e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—head and neck cancer	5.14e-06	6.49e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—head and neck cancer	5.13e-06	6.48e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—head and neck cancer	5.12e-06	6.47e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GPX1—head and neck cancer	5.09e-06	6.43e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—AKT1—head and neck cancer	5.09e-06	6.43e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.09e-06	6.43e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.06e-06	6.39e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.04e-06	6.37e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.02e-06	6.34e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AKT1—head and neck cancer	4.79e-06	6.06e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—head and neck cancer	4.77e-06	6.03e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AKT1—head and neck cancer	4.71e-06	5.94e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—head and neck cancer	4.7e-06	5.94e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	4.61e-06	5.82e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TYMS—head and neck cancer	4.6e-06	5.81e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—head and neck cancer	4.58e-06	5.79e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTM1—head and neck cancer	4.54e-06	5.74e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.54e-06	5.74e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—AKT1—head and neck cancer	4.54e-06	5.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—head and neck cancer	4.42e-06	5.59e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GPX1—head and neck cancer	4.35e-06	5.5e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP1A1—head and neck cancer	4.31e-06	5.44e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—head and neck cancer	4.3e-06	5.44e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—head and neck cancer	4.25e-06	5.37e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.14e-06	5.23e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—head and neck cancer	4.02e-06	5.07e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—head and neck cancer	4.01e-06	5.07e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—head and neck cancer	3.99e-06	5.05e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—head and neck cancer	3.95e-06	5e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	3.94e-06	4.98e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—AKT1—head and neck cancer	3.92e-06	4.95e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK3—head and neck cancer	3.78e-06	4.77e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AKT1—head and neck cancer	3.77e-06	4.76e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—head and neck cancer	3.71e-06	4.68e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.68e-06	4.65e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—head and neck cancer	3.66e-06	4.63e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—head and neck cancer	3.65e-06	4.61e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—head and neck cancer	3.62e-06	4.57e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—head and neck cancer	3.61e-06	4.56e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK1—head and neck cancer	3.59e-06	4.54e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—head and neck cancer	3.59e-06	4.54e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TYMS—head and neck cancer	3.55e-06	4.48e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.54e-06	4.47e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AKT1—head and neck cancer	3.51e-06	4.44e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.51e-06	4.43e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—head and neck cancer	3.5e-06	4.42e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—head and neck cancer	3.37e-06	4.25e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GPX1—head and neck cancer	3.36e-06	4.24e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.32e-06	4.2e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.29e-06	4.15e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AKT1—head and neck cancer	3.28e-06	4.14e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AKT1—head and neck cancer	3.22e-06	4.07e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—head and neck cancer	3.21e-06	4.06e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—head and neck cancer	3.21e-06	4.05e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—head and neck cancer	3.19e-06	4.03e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	3.12e-06	3.94e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—head and neck cancer	3.02e-06	3.81e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—head and neck cancer	3e-06	3.79e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AKT1—head and neck cancer	2.98e-06	3.77e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AKT1—head and neck cancer	2.96e-06	3.73e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AKT1—head and neck cancer	2.95e-06	3.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—head and neck cancer	2.89e-06	3.65e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—head and neck cancer	2.87e-06	3.62e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—head and neck cancer	2.8e-06	3.53e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AKT1—head and neck cancer	2.75e-06	3.48e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.62e-06	3.3e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—head and neck cancer	2.61e-06	3.3e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.56e-06	3.24e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT1—head and neck cancer	2.55e-06	3.22e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.47e-06	3.12e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.27e-06	2.86e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—head and neck cancer	2.25e-06	2.85e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—head and neck cancer	2.23e-06	2.82e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKT1—head and neck cancer	2.14e-06	2.7e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKT1—head and neck cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.98e-06	2.5e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.97e-06	2.49e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKT1—head and neck cancer	1.85e-06	2.34e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.84e-06	2.33e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKT1—head and neck cancer	1.84e-06	2.32e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—head and neck cancer	1.72e-06	2.18e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKT1—head and neck cancer	1.65e-06	2.09e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKT1—head and neck cancer	1.61e-06	2.04e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.58e-06	1.99e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKT1—head and neck cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKT1—head and neck cancer	1.29e-06	1.63e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.22e-06	1.54e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKT1—head and neck cancer	9.93e-07	1.25e-05	CbGpPWpGaD
